Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Effects of Photodynamic Therapy, Intravitreal Ranibizumab and Combination for Polypoidal Choroidal Vasculopathy Under 1+PRN Regimen

NCT03459144 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT03459144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03459144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Effects of Photodynamic Therapy, Intravitreal Ranibizumab and Combination for Polypoidal Choroidal Vasculopathy Under 1+PRN Regimen
Lead sponsor
Sun Yat-sen University
Phase
Not applicable
Overall status
Completed
Start date
December 1, 2012
Completion date
July 30, 2015
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

polypoidal choroidal vasculopathy